Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

SHSE:603896 주식 보고서

시가총액: CN¥4.3b

Zhejiang Shouxiangu Pharmaceutical 대차 대조표 상태

재무 상태 기준 확인 5/6

Zhejiang Shouxiangu Pharmaceutical has a total shareholder equity of CN¥2.2B and total debt of CN¥564.3M, which brings its debt-to-equity ratio to 25.3%. Its total assets and total liabilities are CN¥3.1B and CN¥822.6M respectively. Zhejiang Shouxiangu Pharmaceutical's EBIT is CN¥174.3M making its interest coverage ratio -11.1. It has cash and short-term investments of CN¥1.2B.

주요 정보

25.3%

부채 비율

CN¥564.35m

부채

이자 보상 비율-11.1x
현금CN¥1.16b
주식CN¥2.23b
총 부채CN¥822.58m
총 자산CN¥3.05b

최근 재무 상태 업데이트

업데이트 없음

Recent updates

Weak Statutory Earnings May Not Tell The Whole Story For Zhejiang Shouxiangu Pharmaceutical (SHSE:603896)

May 02
Weak Statutory Earnings May Not Tell The Whole Story For Zhejiang Shouxiangu Pharmaceutical (SHSE:603896)

재무 상태 분석

단기부채: 603896's short term assets (CN¥1.5B) exceed its short term liabilities (CN¥378.6M).

장기 부채: 603896's short term assets (CN¥1.5B) exceed its long term liabilities (CN¥443.9M).


부채 대 자본 내역 및 분석

부채 수준: 603896 has more cash than its total debt.

부채 감소: 603896's debt to equity ratio has increased from 1.9% to 25.3% over the past 5 years.

부채 범위: 603896's debt is well covered by operating cash flow (46.6%).

이자 보장: 603896 earns more interest than it pays, so coverage of interest payments is not a concern.


대차 대조표


건강한 기업 발견하기